Unfortunately @Titans19 the question about manufacturing is market sensitive and so one I can't answer.
The current shelf life of Bisantrene is 3 years, but this is really a factor of how long we have been running the stability assays. We continue to assay for stability and as we gather more data I expect the shelf life will be extended. Even if 3 years proves to be the maximum this would be fine for a drug like Bisantrene.
As an aside one thing we have found is Bisantrene is much more stable once made up into solution than the old Lederle datasheets say. It could be that Lederle were just super conservative, but otherwise this is not a bad thing for us.
Ann: Appendix 4C - quarterly, page-3
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.030(2.52%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.16 | $78.70K | 66.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 4561 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
0.030 ( 0.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.19 | $1.22 | $1.16 | 11297 | ||
| Last updated 15.56pm 07/05/2024 ? | |||||
| RAC (ASX) Chart |